SPRY3

Chr X

sprouty RTK signaling antagonist 3

Also known as: spry-3

The SPRY3 protein inhibits the MAPK signaling cascade and negatively regulates neurite branching and complexity during nervous system development. Mutations cause autosomal recessive intellectual developmental disorder with seizures and spasticity, a neurodevelopmental condition affecting cognitive function and motor control. This gene is not highly constrained against loss-of-function variants, consistent with recessive inheritance.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.15
Clinical SummarySPRY3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 1 VUS of 100 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.15LOEUF
pLI 0.004
Z-score 1.26
OE 0.55 (0.291.15)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.02Z-score
OE missense 1.00 (0.871.14)
157 obs / 157.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.55 (0.291.15)
00.351.4
Missense OE1.00 (0.871.14)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 5 / 9.1Missense obs/exp: 157 / 157.7Syn Z: -0.31
DN
0.6939th %ile
GOF
0.73top 25%
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS1
2
Pathogenic
1
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
Likely Pathogenic
0
VUS
1
Likely Benign
0
Benign
0
Total3

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SPRY3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →